We would like to thank our readers, subscribers and collaboration partners for a fruitful 2020, and we wish you all a most wonderful – and safe – holiday season!
2020 has been a very challenging year and a large part of our industry news on our site have consisted of Nordic efforts to handle, treat and prevent COVID-19, but we have also seen Nordic life science companies making progress and announcing positive updates.
Click here to read some of the most popular articles on nordiclifescience.org this year.
Nordic Life Science will be back in January 2021 to provide you with the latest news from our exciting life science industry!
Until then, here are some holiday reading, Editor’s pick:
William Kaelin: Celebrating science
A Nobel Laureate 2019, William Kaelin feels he has been fortunate in his scientific career. His contributions have had a great impact, not least within cancer treatment, and for future generations he emphasizes the importance of supporting basic science.
COVID-19 vaccines: CEPI steps up
Since launching at Davos in 2017, an Oslo-based global organization has been accelerating pandemic preparations.
Finding the right rhythm – A Nobel discovery
The Nobel Prize in Chemistry 2019 recognized the creation of a rechargeable world that paved the way for pacemakers.
Brick by brick – The Recipharm journey
2020 is the year Recipharm celebrates 25 years of CDMO business. Chief Executive Officer and co-founder, Thomas Eldered looks back upon milestones, crucial turning points and the company’s goal of simplifying a product’s journey to market.
Careers interview: An appetite for innovation
Business development in a clinical stage vaccine company is constantly changing, intellectually challenging and meaningful job that pushes developments in society. Caspar Foghsgaard is Director of Business Development at the Norwegian vaccine platform company Vaccibody.
Nordic COVID-19 initiatives and the potential of joint life science efforts
The task of NordForsk is to facilitate research collaboration in the Nordic region, and within life sciences this is perhaps now more important than ever.